@misc{Qi_X-2020_8357,
title = {Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study},
author = {Qi, X. and Liu, Y. and Wang, J. and Fallowfield, J. and Wang, J. and Li, X. and Shi, J. and Pan, H. and Zou, S. and Zhang, H. and Chen, Z. and Li, F. and Luo, Y. and Mei, M. and Liu, H. and Wang, Z. and Li, J. and Yang, H. and Xiang, H. and Li, X. and Liu, T. and Zheng, M. and Liu, C. and Huang, Y. and Xu, D. and Li, X. and Kang, N. and He, Q. and Gu, Y. and Zhang, G. and Shao, C. and Liu, D. and Zhang, L. and Li, X. and Kawada, N. and Jiang, Z. and Wang, F. and Xiong, B. and Takehara, T. and Rockey, D.},
month = {may},
year = {2020},
abstract = {In this study we provide the first report of the characteristics, comorbidities, laboratory and x-ray findings, and clinical outcomes in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected patients with pre-existing liver cirrhosis. The cause of death in most patients was respiratory failure rather than progression of liver disease. Lower numbers of blood lymphocytes and platelets, and higher bilirubin levels might represent indicators of poor outcome in this patient population.},
pages = {433-436},
volume = {70},
issue = {2},
journal = {Gut},
publisher = {BMJ Publishing Group},
url = {https://doi.org/10.1136/gutjnl-2020-321666},
}
